by Richard Cruse | Jul 10, 2023 | News
ProFactor Pharma Ltd (PFP) is excited to welcome Eugenia Wachters, who joined the company as Chief Operating Officer on 1st July 2023. Eugenia will be responsible for leading the company’s business operations, working closely with the PFP Executive team and Board...
by Richard Cruse | Apr 19, 2023 | News
The World Federation of Hemophilia (WFH) have set April 17, 2023 as World Hemophilia Day. The theme of the event this year is “Access for All: Prevention of bleeds as the global standard of care”. Building on last year’s theme, the call to action for the community in...
by Richard Cruse | Sep 20, 2022 | News
ProFactor Pharma is pleased to announce completion of a further investment round. The investment will enable PFP to progress the company’s clinical stage Recombinant Human Factor VIII to market and to engage with commercial licensing opportunities. The funding...
by Richard Cruse | Nov 24, 2021 | News
Published on November 23, 2021 By Deborah Johnson Interview: Ending the haemophilia drug shortage Jaymin Amin, CEO of ProFactor Pharma (PFP), discusses the company’s life-changing, and lifesaving, work. PFP says it has developed a low-cost production process for...
by Richard Cruse | Mar 31, 2021 | News
ProFactor Pharma Ltd (PFP) the developer of a unique, ultra high yielding cell line for the manufacture of recombinant human factor VIII (rhVIII), is pleased to announce the recent issuance of Indian Patent No. 361851 and Eurasian Patent No 529615EA. This patent...